Average metastasis-free survival of patients drops from 48.7 months (±3.5; 95% CI = 41.8–55.6) to 28.0 months (±4.1; 95% CI =  19.9–36.0) when S100P is highly expressed in the primary tumour. This evidence concerns the gene S100P and neoplasm.